White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and

Liana F Leiria1, Mateus D Severo2, Priscila S Ledur2

  • 1Cardiology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

Journal of Diabetes
|October 21, 2014
PubMed

Insights

In diabetic patients on treatment, masked uncontrolled hypertension (MUH) was more prevalent than expected. Different hypertension phenotypes showed varying associations with left ventricle hypertrophy but not clearly with kidney or diastolic function.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • The association between hypertensive phenotypes (controlled hypertension, white-coat effect, masked uncontrolled hypertension, sustained hypertension) and target organ damage in treated diabetic hypertensive patients is not well-established.
  • Current cut-off points for office and 24-hour ambulatory blood pressure monitoring (ABPM) may influence these associations.

Purpose of the Study:

  • To evaluate the prevalence of four hypertensive phenotypes in treated diabetic patients using current ABPM cut-off points.
  • To assess the association of these phenotypes with left ventricle hypertrophy (LVH), diastolic function, and nephropathy.

Main Methods:

  • A cross-sectional study involving 304 treated hypertensive diabetic patients (mean age 57.6 years).
  • Patients underwent 24-hour ABPM and echocardiography.
  • Hypertensive phenotypes were classified based on office and ABPM readings: CH, WCE, MUH, and SH.

Main Results:

  • Prevalences were: sustained hypertension (SH) 36.8%, controlled hypertension (CH) 27.3%, masked uncontrolled hypertension (MUH) 18.8%, and white-coat effect (WCE) 17.1%.
  • MUH prevalence was higher than previously reported.
  • A significant increasing trend in left ventricle hypertrophy (LVH) was observed across the four groups (P < 0.001).
  • No clear dose-response relationship was found between phenotypes and nephropathy or diastolic function.

Conclusions:

  • Ambulatory blood pressure monitoring (ABPM) is valuable for risk stratification in high-risk patients, despite limitations.
  • Longitudinal studies are needed to further clarify the role of ABPM.
  • The choice of normality cut-off points for office and ABPM significantly impacts the prevalence of white-coat hypertension (WCH) and MUH.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
747
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
1.5K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.6K